A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

NCT00140946 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

546

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK0476; montelukast sodium/Duration of Treatment: 16 weeks
DRUG: Comparator: placebo / Duration of Treatment: 16 weeks

Sponsor

Organon and Co